E-MED: R�union Internationale sur la Recherche et le D�veloppement
---------------------------------------------------------------------
International Meeting on a global framework for supporting health research
and development (R&D) in areas of market and public policy failure.
29th April, 2003 from 08:30 to 18:00 at
The International Conference Centre of Geneva (CICG)
15, rue de Varemb�
1211 Geneva, Switzerland
Provisional Agenda
Registration: from 08:30 to 09:00
09:00 to 09:15
Opening Comments
Sir John Sulston, Founding Director of the Wellcome Trust Sanger Institute,
Nobel Prize for Physiology or Medicine 2002, UK
09:15 to 10:45
Panel 1
The Crisis in Health R&D: Where is market driven R&D inadequate for public
health needs?
Moderator: to be announced
R&D and drugs for Neglected Patients
Bernard P�coul, Director, Campaign for Access to Essential Medicines,
M�decins sans Fronti�res (MSF), Switzerland
Funding challenges for R&D in Africa
Monique Wasunna, Kenya Medical Research Institute, Kenya, (invited)
Better drugs to treat people living with AIDS
Bob Huff, GMHC Treatment Issues, Gay Men's Health, Crisis, USA
AIDS Vaccine research, a global responsibility
Saul Walker, International AIDS Vaccine Initiative, (IAVI), USA
Research on Drugs to Treat TB
Joelle Tanguy, Global TB Alliance, USA
Open Source Research
Tim Hubbard, Wellcome Trust Sanger Institute, UK
Existing framework for R&D
Janis Lazdins, World Health Organization ? Programme for Research and
Training in Tropical Diseases (WHO-TDR), Switzerland
Discussion
10:45 to 11:00
Break
11:00 to 12:30
Panel 2
Current Global frameworks for Funding R&D
Moderator: Julian Fleet, UNAIDS, Switzerland (invited)
Intellectual Property, R&D and Development
Charles Clift, DFID, Commission on Intellectual Property Rights, UK
G8 and EC strategies to promote R&D
Lieve Fransen, European Commission, Belgium (invited)
Identifying research gaps and addressing the need for transparency of
investment flows
Louis Currat, Global Forum for Health Research, Switzerland
Present global mechanisms for R&D deliver
erry Reichman, Duke University School of Law, USA, (invited)
Lessons from Public-Private Partnerships
Roy Widdus, Initiative on Public-Private Partnerships forHealth, Switzerland
Lessons from the WHO Framework Convention on Tobacco Control
Derek Yach, World Health Organization, Switzerland
Discussion
12:30 to 14:00
Lunch
14:00 to 15:30
Panel 3
Developing a new framework for funding R&D
Moderator: Faizel Ismail, Mission of South Africa, Switzerland
New Treaty Frameworks for Sharing Burden of Funding R&D
James Love, Consumer Project on Technology, USA
Issues presented by WTO Agreements
Jayashree Watal, World Trade Organization, Switzerland
Human Rights and R&D funding framework
Tenu Avafia, Legal Assistance Centre, Namibia
Technology Transfer Objectives of an R&D Treaty
Pedro Roffe, UNCTAD, Geneva
The World Health Report 2004 and the 2004 Mexico
Ministerial Summit on Health R&D
Tikki Pang, World Health Organization, Switzerland
Discussion
15:30 to 16:00
Break
16:00 to 18:00
Panel 4
How do we develop proactive policy in shaping R&D?
Moderator: Catherine Hodgkin, Royal Tropical Institute,
The Netherlands
WHO View
Jonathan Quick, World Health Organization, Switzerland
Industry View
Gill Samuels, Pfizer, UK
Developing Country role in shaping R&D policy agenda
Sisule Fredrick Musungu, South Centre, Geneva
The World Health Assembly Agenda on Intellectual Property, Innovation and
Public Health
Jorge Bermudez, Fiocruz, Brazil
NGO view
Philippa Saunders, Oxfam, UK
NGO view
Ellen 't Hoen, Campaign for Access to Essential Medicines,
M�decins sans Fronti�res, France
Next steps towards an international R&D convention
Sir John Sulston, Founding Director of the Wellcome
Trust Sanger Institute, UK
Discussion
Closing of the meeting
For additional information, please contact Ms Joy Spencer in Washington at
joy.spencer@cptech.org (+1.202.387.8030, fax +1.202.234.5176) or Ms Mai Do
in Paris
at: mdo@paris.msf.org (+ 33 1 4021 2825, fax + 33 1 4021 2962)
--
Adresse pour les messages destin�s au forum E-MED:
<e-med@usa.healthnet.org>
Pour r�pondre � un message envoyer la r�ponse au forum
ou directement � l'auteur.
Pour toutes autres questions addresser vos messages � :
<e-med-help@usa.healthnet.org>